5220642022-07-012022-09-305220642022-09-305220642022-03-315220642022-04-012022-09-305220642022-07-012022-09-30in-bse-fin:OtherExpenses1Member5220642022-04-012022-09-30in-bse-fin:OtherExpenses1Member5220642022-07-012022-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15220642022-04-012022-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares522064HONDAPOWERNOTLISTEDINE634A01018Honda India Power Products LimitedEquity2022-04-012023-03-312022-11-082022-10-27INRLakhsHalf yearlySingle segmentPower Products2022-11-0811:18:002022-11-0811:58:00trueCash Flow IndirectNot applicable2022-07-012022-09-30UnauditedStandalone394080000055500000399630000018242000002893000001764000003121000005000004990000077530000034277000005686000000568600000154500000-1010000014440000004242000000000424200000-100000424100000001014000001041.8241.820041.8241.821. The above financial results of the Company have been prepared in accordance with the recognition and management principles of Indian Accounting Standards ("Ind AS") as notified under the Companies (Indian Accounting Standards) Rules, 2015 and relevant amendment rules issued thereafter. <BR> <BR> 2. The above results were reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on November 8, 2022. <BR> <BR> 3. The Company is in the business of “Power Products” which is a single business segment in accordance with Ind AS-108 "Operating Segment" notified pursuant to Companies (Accounting Standards) Rule, 2015. <BR> <BR> 4. The Company’s major export is to its fellow subsidiaries located in the United States of America (USA), Canada, Australia, United Kingdom (UK) and the countries in European Union (EU) and European Free Trade Association (EFTA). In line with the regulatory requirements of the above-mentioned countries, the Company is required to do product line testing (PLT) on regular intervals for one of the key products being sold to these countries to comply with emission norms. Results of such testing done during 2nd half of the financial year 2021-22, were not in confirmation with required norms in case of Australia, UK, and the countries in EU/EFTA and in case of USA and Canada, testing results exceeded the declarations on the products but same were within the required norms in respective countries. As a precautionary measure, the Company stopped dispatches during March 2022 and is further analyzing the root cause. The Company is assessing the coverage and its monetary impact which may be in the form of replacement cost of components in the products and regulatory fees, if any, in the UK, EU region and Australia. The Company would be engaging with a lawyer after ascertaining the root cause for this issue along with countermeasures for taking up the matter with regulatory authorities in related regions. Considering the above-mentioned facts, it is not practicable for the management to make reliable estimate regarding the obligation of the Company in respect of the above matter. Accordingly, there exists contingent liability in respect of this matter and no provision has been recognized in the current unaudited financial results for the quarter and six months ended 30 September 2022. <BR> <BR> During the September quarter, the Company has started export sales to USA and Canada under the revised declaration. <BR> 2022-04-012022-09-30UnauditedStandalone594140000011300000060544000003506300000516500000-568900000695900000110000098200000117110000054202000006342000000634200000182400000-2150000016090000004733000000000473300000-200000473100000001014000001046.6646.660046.6646.66Other Expenses775300000Other Expenses117110000092260000014500000001370000028000000000012200000122000009260000045320000015116000002384600000029850000013806000002878100000074700000463190000006653000007681800000009193400000101400000691830000070197000007019700000009000000900000093000000001830000001384000000315300000169930000019230000026380000000215540000000217370000091934000001100000-6149000005717000000-69000008000000-140000001947000000-1021000000982000000-66000000863000000-18500000071200000000-30000000013090000076510000000098300000066680000000000000130000014020000000025000000000000219600000621400000000002140000000-5218000000000000000023000000120000000-35000001415000002030000016180000012188000001380600000Remeasurement of post- employment benefit obligations-100000-100000Remeasurement of post- employment benefit obligations-200000-20000000